Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.22 +0.02 (+0.48%)
At close: Nov 11, 2026 · 4:00 PM EST

Atea Pharmaceuticals (AVIR) Revenue (2021)

Updated

Atea Pharmaceuticals (AVIR) reported Revenue of $192.18 million for Q4 2021, up 485.7% from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Revenue (2021) Analysis & Trends

For FY2021, Atea Pharmaceuticals posted Revenue of $351.37 million, up 622.5% from FY2020.

  • By year, Revenue came in at $48.63 million in FY2020.
  • Per Business Quant data, the three quarters before Q4 2021 came in at $32.81 million (Q3 2021), $60.39 million (Q2 2021) and $65.99 million (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Atea Pharmaceuticals 337.28 Mn -631.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 192.18 Mn
Sep 30, 2021 32.81 Mn
Jun 30, 2021 60.39 Mn
Mar 31, 2021 65.99 Mn
API Access

Atea Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=AVIR&period=max&api_key=YOUR_API_KEY